Showing results (41-50 of 554) with videos related to
Sort By:
Pageof 56
Lab on a Chip|January 6, 2017
3D microvascular model recapitulates the diffuse large B-cell lymphoma tumor microenvironment in vitroRobert G Mannino, Adriana N Santiago-Miranda, Pallab Pradhan, et al.Experimental Hematology & Oncology|March 21, 2023
PD-L1+ macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphomaRaphael E Steiner, Edwin R Parra, Francisco Vega, et al.Frontiers in Oncology|April 12, 2021
Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for SynergyPenny Q Fang, Jillian R Gunther, Susan Y Wu, et al.Journal of Hematology & Oncology|June 7, 2015
Targeting Wnt pathway in mantle cell lymphoma-initiating cellsRohit Mathur, Lalit Sehgal, Frank K Braun, et al.Haematologica|October 16, 2016
Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugsRohit Mathur, Lalit Sehgal, Ondrej Havranek, et al.Blood|September 17, 2010
8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphomaJennifer B Dennison, Mala Shanmugam, Mary L Ayres, et al.Vaccine|October 13, 2010
Generation of an immune microenvironment as a novel mechanism for myotoxins to potentiate genetic vaccinesHong Qin, Soung-Chul Cha, Sattva S Neelapu, et al.Expert Review of Anticancer Therapy|April 22, 2024
Network meta-analysis of CAR T-Cell therapy for the treatment of 3L+ R/R LBCL after using published comparative studiesOlalekan O Oluwole, Sattva S Neelapu, Markqayne D Ray, et al.Blood|March 14, 2007
A novel proteoliposomal vaccine elicits potent antitumor immunity in miceMircea C Popescu, Richard J Robb, Michael M Batenjany, et al.Leukemia & Lymphoma|September 14, 2020
Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphomaFelipe Samaniego, Peter McLaughlin, Sattva S Neelapu, et al.Pageof 56